✦ LIBER ✦

Monitoring the Size and Response of Locally Advanced Breast Cancers to Neoadjuvant Chemotherapy (Weekly Paclitaxel and Epirubicin) with Serial Enhanced MRI

✍ Scribed by Yun-Chung Cheung; Shih-Cheh Chen; Min-Ying Su; Lai-Chu See; Swei Hsueh; Hsien-Kun Chang; Yung-Chang Lin; Chien-Sheng Tsai

Book ID: 110415642
Publisher: Springer US
Year: 2003
Tongue: English
Weight: 95 KB
Volume: 78
Category: Article
ISSN: 0167-6806
DOI: 10.1023/a:1022153327339

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Role of dynamic contrast enhanced MRI in

Role of dynamic contrast enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy

✍ Martin D. Pickles; Martin Lowry; David J. Manton; Peter Gibbs; Lindsay W. Turnbu 📂 Article 📅 2005 🏛 Springer US 🌐 English ⚖ 338 KB

Evaluation of dynamic contrast-enhanced

Evaluation of dynamic contrast-enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy

✍ Xiaohong Wang; Weijun Peng; Hongna Tan; Chao Xin; Jian Mao 📂 Article 📅 2010 🏛 Springer 🌐 English ⚖ 403 KB

Combined use of MRI and PET to monitor r

Combined use of MRI and PET to monitor response and assess residual disease for locally advanced breast cancer treated with neoadjuvant chemotherapy1

✍ Chen, Xiaoming; Moore, Mark O.; Lehman, Constance D.; Mankoff, David A.; Lawton, 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 198 KB

Evaluation of response to neoadjuvant ch

Evaluation of response to neoadjuvant chemoradiotherapy for locally advanced breast cancer with dynamic contrast-enhanced MRI of the breast

✍ P.J Drew; M.J Kerin; T Mahapatra; C Malone; J.R.T Monson; L.W Turnbull; J.N Fox 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 88 KB

Contrast-enhanced US and MRI for assessi

Contrast-enhanced US and MRI for assessing the response of breast cancer to neoadjuvant chemotherapy

✍ B. Corcioni; L. Santilli; S. Quercia; C. Zamagni; D. Santini; M. Taffurelli; S. 📂 Article 📅 2008 🏛 Springer-Verlag 🌐 English ⚖ 853 KB

Monitoring the response of patients with

Monitoring the response of patients with locally advanced breast carcinoma to neoadjuvant chemotherapy using [technetium 99m]-sestamibi scintimammography

✍ David A. Mankoff; Lisa K. Dunnwald; Julie R. Gralow; Georgiana K. Ellis; Mariann 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 221 KB 👁 2 views

## BACKGROUND. Mammographic and physical examination assessments of the response of locally advanced breast carcinoma (LABC) to neoadjuvant therapy have been shown to be inaccurate. The authors studied the feasibility and accuracy of [technetium 99m]-sestamibi (MIBI) for monitoring the response of